Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from STAT

10:12 EST 19th January 2019 | BioPortfolio

Here are the most relevant search results for "STAT" found in our extensive news archives from over 250 global news sources.

More Information about STAT on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about STAT for you to read. Along with our medical data and news we also list STAT Clinical Trials, which are updated daily. BioPortfolio also has a large database of STAT Companies for you to search.

Showing News Articles 1–25 of 4,000+ from STAT

Saturday 19th January 2019

Drug maker payments to doctors are linked to higher #opioid overdose deaths. https://buff.ly/2QVX8Tf 

Drug maker payments to doctors are linked to higher #opioid overdose deaths. https://buff.ly/2QVX8Tf 

Friday 18th January 2019

STAT Plus: Atul Gawande has virtually disappeared from the public eye since he took the helm of a mysterious new health care company — and now he's withdrawing from a much-anticipated keynote address. https://buff.ly/2U0E0p0 

STAT Plus: Atul Gawande has virtually disappeared from the public eye since he took the helm of a mysterious new health care company — and now he's withdrawing from a much-anticipated keynote address. https://buff.ly/2U0E0p0 

Opinion: Diagnostic innovations are slowed by bureaucratic roadblocks. https://buff.ly/2DkzY5G 

Opinion: Diagnostic innovations are slowed by bureaucratic roadblocks. https://buff.ly/2DkzY5G 

STAT Plus: As Allergan tries to stall generic competition for its best-selling dry-eye drug Restasis, a small Canadian company is advancing its own medicine that could prove superior. https://buff.ly/2RArccd 

STAT Plus: As Allergan tries to stall generic competition for its best-selling dry-eye drug Restasis, a small Canadian company is advancing its own medicine that could prove superior. https://buff.ly/2RArccd 

Opinion: Places all around the world are using drones to deliver medical supplies that save lives. The U.S. should be doing the same. https://buff.ly/2W2x64D 

Opinion: Places all around the world are using drones to deliver medical supplies that save lives. The U.S. should be doing the same. https://buff.ly/2W2x64D 

In THREE DAYS the application process for #statmadness closes! If you think your institution is the MVP of biomedical innovation then there's no more time to wait. Enter today: https://buff.ly/2CxeD7d pic.twitter.com/DrUkbWruAy

In THREE DAYS the application process for #statmadness closes! If you think your institution is the MVP of biomedical innovation then there's no more time to wait. Enter today: https://buff.ly/2CxeD7d  pic.twitter.com/DrUkbWruAy

Immunomedics remains in a 37-year drug development drought after the FDA rejected its breast cancer drug. https://buff.ly/2FBGAPl 

Immunomedics remains in a 37-year drug development drought after the FDA rejected its breast cancer drug. https://buff.ly/2FBGAPl 

BREAKING: Tufts to review ties to Purdue Pharma after ‘deeply troubling’ disclosures https://buff.ly/2RDUdnq 

BREAKING: Tufts to review ties to Purdue Pharma after ‘deeply troubling’ disclosures https://buff.ly/2RDUdnq 

Tufts to review ties to Purdue Pharma after ‘deeply troubling’ disclosures

Tufts University is reviewing its ties to Purdue Pharma, the maker of OxyContin, after court filings suggested the company sought to gain influence at the university.

Find out how herd immunity works in this clever #animation by @hoganalex and article by @HelenBranswell. https://www.statnews.com/2019/01/18/herd-immunity-disease-health/ … via @statnews

Find out how herd immunity works in this clever #animation by @hoganalex and article by @HelenBranswell. https://www.statnews.com/2019/01/18/herd-immunity-disease-health/ … via @statnews

Herd immunity can prevent the spread of disease to keep us all healthy. Watch how:pic.twitter.com/iKLDqbs2hn

Herd immunity can prevent the spread of disease to keep us all healthy. Watch how: pic.twitter.com/iKLDqbs2hn

STAT Plus: After its own megamerger, Celgene signs deals with two biotechs for their cancer drugs

Two Massachusetts biotech startups working on potential cancer treatments said they have made deals to collaborate with Celgene.

Increased marketing of #opioids to physicians resulted in more prescribing and, subsequently, more deaths from overdose, according to a new study. https://buff.ly/2CshTkk 

Increased marketing of #opioids to physicians resulted in more prescribing and, subsequently, more deaths from overdose, according to a new study. https://buff.ly/2CshTkk 

Drug maker payments to doctors are linked to higher opioid overdose deaths

Increased marketing of opioids to physicians resulted in more prescribing and, subsequently, more deaths from overdose, according to a new study.

A voluntary program will let Medicare Part D plans, which share costs of prescription drug insurance with the government, to keep more of the savings they negotiate. https://buff.ly/2CuINrI 

A voluntary program will let Medicare Part D plans, which share costs of prescription drug insurance with the government, to keep more of the savings they negotiate. https://buff.ly/2CuINrI 

Medicare experiment could put more pressure on insurers to save money on prescription drugs

A voluntary program will let Medicare Part D plans, which share costs of prescription drug insurance with the government, to keep more of the savings they negotiate.

STAT Plus: From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. Recognize anyone? https://buff.ly/2Csukg1 

STAT Plus: From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. Recognize anyone? https://buff.ly/2Csukg1 

ICYMI last night, the FDA rejected a breast cancer drug from Immunomedics, a biotech that was hoping for its first approval in 37 years. ⁦@adamfeuerstein⁩ reports: https://www.statnews.com/2019/01/17/fda-rejects-immunomedics-breast-cancer-drug/ …

ICYMI last night, the FDA rejected a breast cancer drug from Immunomedics, a biotech that was hoping for its first approval in 37 years. ⁦ @adamfeuerstein⁩ reports: https://www.statnews.com/2019/01/17/fda-rejects-immunomedics-breast-cancer-drug/ …

In THREE DAYS the application process for #statmadness closes! If your institution is working on the next advances in science and medicine then there's no more time to wait. Enter today: https://buff.ly/2FwhXDu pic.twitter.com/Epaa0NA6JC

In THREE DAYS the application process for #statmadness closes! If your institution is working on the next advances in science and medicine then there's no more time to wait. Enter today: https://buff.ly/2FwhXDu  pic.twitter.com/Epaa0NA6JC

STAT Plus: Why a company's interpretation of a study about pancreatic cancer should be seen with skepticism. $TYME https://buff.ly/2FKlZaW 

STAT Plus: Why a company's interpretation of a study about pancreatic cancer should be seen with skepticism. $TYME https://buff.ly/2FKlZaW 

Pharmalot.. Pharmalittle.. Good Morning.. FDA will furlough more workers, an FDA panel splits on a diabetes drug & more interesting news, plus weekend daydreams.. https://www.statnews.com/pharmalot/2019/01/18/fda-shutdown-diabetes-drug-prices/ … #phar

Pharmalot.. Pharmalittle.. Good Morning.. FDA will furlough more workers, an FDA panel splits on a diabetes drug & more interesting news, plus weekend daydreams.. https://www.statnews.com/pharmalot/2019/01/18/fda-shutdown-diabetes-drug-prices/ … #pharma #opioids #Med

STAT Plus: Pharmalittle: FDA will furlough more people; FDA panel is divided over new diabetes drug

An FDA advisory panel was divided over whether to recommend approval of a Type 1 diabetes treatment developed by Lexicon Pharmaceuticals and Sanofi.

Akili hopes its video game will win FDA approval for kids with ADHD. David Collins is making sure its sounds will keep gamers playing. https://buff.ly/2QY1clQ 

Akili hopes its video game will win FDA approval for kids with ADHD. David Collins is making sure its sounds will keep gamers playing. https://buff.ly/2QY1clQ 

STAT Plus: Tyme Technologies misleads with new data on pancreatic cancer drug

Why a company's interpretation of a study about pancreatic cancer should be seen with skepticism.

Opinion: It's a long and winding road to bringing diagnostic innovations to the U.S. market. We need to clear the roadblocks. https://buff.ly/2RCOX3q 

Opinion: It's a long and winding road to bringing diagnostic innovations to the U.S. market. We need to clear the roadblocks. https://buff.ly/2RCOX3q 


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks